Abstract | BACKGROUND:
Brain death has been identified as an independent risk factor for chronic allograft dysfunction. In two independent retrospective clinical studies, we showed that dopamine treatment of brain-dead donors improves long-term kidney graft survival. The mechanisms underlying the protective effects of dopamine treatment in vivo have not been identified. To elucidate the mechanisms underlying the protective effect of dopamine on kidneys of brain-dead donors, we studied a model for brain death in rats. METHODS: In F344 rats, brain death was induced by epidural inflation of a 3F Fogarty catheter. Apneic animals were mechanically ventilated, and clinically relevant dosages of dopamine (2, 6, 10, or 14 microg/kg/min) were given for 6 hr from the onset of brain death. Ventilated, non- brain-dead animals served as controls. RESULTS: CONCLUSION: We identified several mechanisms underlying the protective effects of dopamine treatment on kidney grafts. The identification of these mechanisms may help to design more effective future strategies for treatment of cadaveric kidney donors.
|
Authors | Meike Schaub, Christian J Ploetz, Daniel Gerbaulet, Liu Fang, Pia Kranich, Thomas H W Stadlbauer, Uwe Goettman, Benito A Yard, Claude Braun, Peter Schnuelle, Fokko J van der Woude |
Journal | Transplantation
(Transplantation)
Vol. 77
Issue 9
Pg. 1333-40
(May 15 2004)
ISSN: 0041-1337 [Print] United States |
PMID | 15167587
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Tumor Necrosis Factor-alpha
- Heme Oxygenase (Decyclizing)
- Heme Oxygenase-1
- Dopamine
|
Topics |
- Animals
- Blood Pressure
- Blotting, Western
- Brain Death
- Dopamine
(pharmacology)
- Gene Expression
(immunology)
- Heme Oxygenase (Decyclizing)
(metabolism)
- Heme Oxygenase-1
- Kidney
(immunology)
- Kidney Transplantation
(immunology)
- Male
- Nephritis
(drug therapy, immunology)
- Oxidative Stress
(drug effects, immunology)
- Rats
- Rats, Inbred F344
- Reverse Transcriptase Polymerase Chain Reaction
- Tissue Donors
- Tumor Necrosis Factor-alpha
(genetics)
|